Current Prices from OnKure Therapeutics, Inc. - Class A Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change	Daily Change %
NASDAQ	OKUR	USD	06.02.2025 21:59	5,65 USD	6,08 USD	-7,07 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	-7,98 %	-34,45 %	-66,03 %	-66,92 %	-66,92 %	-66,92 %

Company Profile for OnKure Therapeutics, Inc. - Class A Common Stock Share

OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. The company focuses on developing selective inhibitors of histone deacetylases. Its portfolio includes OKI-179, an inhibitor for the treatment of both hematological and solid tumors. The company was incorporated in 2011 and is based in Boulder, Colorado.

Company Data

Name OnKure Therapeutics, Inc. - Class A Common Stock

Company OnKure Therapeutics, Inc.

Symbol OKUR

Website https://onkuretherapeutics.com

Primary Exchange

NASDAQ

ISIN US68277Q1058

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Dr. Nicholas A. Saccomano Ph.D.

Market Capitalization 72 Mio

Country United States of America

Currency USD

Employees 0,1 T

Address 6707 Winchester Circle, 80301 Boulder

ID Changes

Date	From	To
07.10.2024	RPHM	OKUR

Ticker Symbols

Name	Symbol
NASDAQ	OKUR

More Shares

Investors who OnKure Therapeutics, Inc. - Class A Common Stock hold also have the following shares in their portfolio:

ADVISORSHARES FOCUSED EQUITY ETF ETF

DZ BANK IS.A1308 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog